Anti-atherosclerotic effect of E5324, an inhibitor of acyl-CoA:cholesterol acyltransferase, in Watanabe heritable hyperlipidemic rabbits

Atherosclerosis

Volumn 124, Issue 2, 1996, Pages 203-210

  Kogushi, Motoji ^a   Tanaka, Hiroshi ^a   Ohtsuka, Issei ^a   Yamada, Toshie ^a   Kobayashi, Hiroko ^a   Saeki, Takao ^a   Takada, Masahiro ^a   Hiyoshi, Hironobu ^a   Yanagimachi, Mamoru ^a   Kimura, Teiji ^a   Yoshitake, Shinji ^a   Saito, Isao ^a  

^a EISAI CO LTD   (Japan)

Author keywords

Acyl CoA:cholesterol acyltransferase; Atherosclerosis; E5324; WHHL rabbit

Indexed keywords

ACYL COENZYME A; ANTILIPEMIC AGENT; CHOLESTEROL ACYLTRANSFERASE; E 5324; PROBUCOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RABBIT;

EID: 0030565007     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(96)05831-5     Document Type: Article

References (27)

1. [1] Suckling KE, Stange EF. Role of acyl CoA:cholesterol acyltransferase in cellular cholesterol metabolism. J Lipid Res 1985;26:647.
2. [2] Vahouny GV, Treadwell CR. Changes in lipid composition of lymph during cholesterol absorption in rat. Am J Physiol 1957;191:179.
3. [3] Heider JG, Pickens CE, Kelly LA. Role of acyl CoA:cholesterol acyltransferase in cholesterol absorption and its inhibition by 57-118 in the rabbit. J Lipid Res 1983;24:1127.
4. [4] Bennett CS, Tercyak AM. Reduced cholesterol transmucosal transport in rats with inhibited mucosal acyl CoA:cholesterol acyltransferase and normal pancreatic function. J Lipid Res 1984;25:148.
5. [5] Largis EE, Wang CH, De Vries VG, Schaffer SA. CL277082: a novel inhibitor of ACAT-catalyzed cholesterol esterification and cholesterol absorption. J Lipid Res 1989;30:681.
6. [6] Brown MS, Ho YK, Goldstein JL. The cholesterol ester cycle in macrophage foam cells. J Biol Chem 1980;255:9344.
7. [7] Bocan TMA, Bak Mueller S, Uhlendorf PD, Newton RS, Krause BR. Comparison of CI-976, an ACAT inhibitor, and selected lipid-lowering agents for anti-atherosclerotic activity in iliac-femoral and thoracic lesions. Arterioscler Thromb 1991;11:1830.
8. [8] Kimura T, Takase Y, Hayashi K et al. Structure-activity relationship of N-[2-(dimethylamino)-6-[3-(5-methyl-4-phenyl-1H-imidazol-1-yl)propoxy]-phenyl]-N′-pentylurea and analogues. Novel potent inhibitors of acyl CoA:cholesterol O-acyltransferase with anti-atherosclerotic activity. J Med Chem 1993;36:1630.
9. [9] Kimura T, Watanabe M, Matsui M et al. Structure-activity relationship of a series of phenyl ureas linked to 4-phenylimidazole. Novel potent inhibitors of acyl-CoA:cholesterol O-acyltransferase with anti-atherosclerotic activity. J Med Chem 1993;36:1641.
10. [10] Tanaka H, Ohtsuka I, Kogushi M et al. Effect of the acyl-CoA:cholesterol acyltransferase inhibitor, E5324, on experimental atherosclerosis in rabbits. Atherosclerosis 1994;107:187.
11. [11] Tanzawa K, Shimada Y. Kuroda M, Tsujita Y, Arai M, Watanabe H. WHHL-rabbit: a low density lipoprotein receptor-deficient animal model for familial hypercholesterolemia. FEBS Lett 1980;118:81.
12. [12] Watanabe Y. Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-rabbit). Atherosclerosis 1980;36:261.
13. [13] Kita T, Nagano Y, Yokode M, Ishii K, Kume N, Ooshima A, Yoshida H, Kawai C. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci USA 1987;84:5928.
14. [14] White DA, Middleton B, Pawson S et al. Regulation of dolichol and cholesterol biosynthesis in cholesterol-fed rabbits. Arch Biochem Biophys 1980;208:439.
15. [15] Morisaki N, Mayuoka N, Shirai Y, Saito Y, Kumagai A. Studies on acyl CoA synthetase in rat arterial wall. Atherosclerosis 1980;37:439.
16. [16] Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37:911.
17. [17] Kano M, Teshima T, Tanaka M et al. The use of thinchrograph for the determination of serum phospholipid fractions in hyperlipidemic patients. Saishinkagaku 1976;31:2002 (in Japanese).
18. [18] Lowry OH, Rosebrough NJ, Farr LA, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1954;193:265.
19. [19] Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 1986;232:34.
20. [20] Subbiah MTR, Yunker RL, Rymaszewski Z, Kottke BA, Bale LK. Cholestyramine treatment in early life of low-density lipoprotein receptor deficient Watanabe rabbits: decreased aortic cholesteryl ester accumulation and atherosclerosis in adult life. Biochim Biophys Acta 1987;920:251.
21. [21] Watanabe Y, Ito T, Shiomi M, Tsujita Y, Kuroda M, Arai M, Fukami M, Tamura A. Preventive effect of pravastatin sodium, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on coronary atherosclerosis and xanthoma in WHHL rabbits. Biochim Biophys Acta 1988;960:294.
22. [22] Shiomi M, Ito T, Watanabe Y, Tsujita Y, Kuroda M, Arai M, Fukami M, Fukushige J, Tamura A. Suppression of established atherosclerosis and xanthomas in mature WHHL rabbits by keeping their serum cholesterol levels extremely low. Effect of pravastatin sodium in combination with cholestyramine. Atherosclerosis 1990;83:69.
23. [23] Nose K, Hayashi K, Iwase T, Sawa Y, Horie T. Pharmacokinetics and metabolic fate of the acyl CoA:cholesterol acyltransferase inhibitor, n-butyl-N′-[2-[3-(5-ethyl-4-phenyl-1H-imidazol-1-yl)propoxy]-6-methylphenyl]urea, E5324 (abstract), Drugs Affecting Lipid Metabolism XI, Florence, Italy; 1992, p. 89.
24. [24] Kogushi M, Tanaka H, Kobayashi H, Yamada T, Ohtsuka I, Kimura T, Saito I. Effects of E5324, a novel inhibitor of acyl-CoA:cholesterol acyltransferase, on cholesteryl ester synthesis and accumulation in macrophages. Jpn J Pharmacol 1995;68:191.
25. [25] Warner GJ, Stoudt G, Ramberger M, Johnson WJ, Rothblat GH. Cell toxicity induced by inhibition of acyl coenzyme A:cholesterol acyltransferase and accumulation of unesterified cholesterol. J Biol Chem 1995;270:5772.
26. [26] Cheng D, Chang CCY, Qu X, Chang TY. Activation of acyl-coenzyme A:cholesterol acyltransferase by cholesterol or by oxysterol in a cell-free system. J Biol Chem 1995;270:685.
27. [27] Daugherty A, Rateri DL. Failure of the intracellular itinerary of β very low density lipoproteins to augment cholesterol esterification in macrophages from Watanabe heritable hyperlipidemic rabbits. J Biol Chem 1991;266:17269.